Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

InspireMD Q3 EPS $(0.15), Inline, Sales $1.56M Beat $1.50M Estimate

Author: Benzinga Newsdesk | November 06, 2023 08:04am
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 74.14 percent increase over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $1.56 million which beat the analyst consensus estimate of $1.50 million by 3.73 percent. This is a 8.74 percent increase over sales of $1.43 million the same period last year.

Posted In: NSPR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist